Refeeding syndrome is associated with increased mortality in malnourished medical inpatients: Secondary analysis of a randomized trial.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
entrez:
3
1
2020
pubmed:
3
1
2020
medline:
15
1
2020
Statut:
ppublish
Résumé
Whether the occurrence of refeeding syndrome (RFS), a metabolic condition characterized by electrolyte shifts after initiation of nutritional therapy, has a negative impact on clinical outcomes remains ill-defined. We prospectively investigated a subgroup of patients included in a multicentre, nutritional trial (EFFORT) for the occurrence of RFS. In this secondary analysis of a randomized-controlled trial investigating the effects of nutritional support in malnourished medical inpatients, we prospectively screened patients for RFS and classified them as "RFS confirmed" and "RFS not confirmed" based on predefined criteria (i.e. electrolyte shifts, clinical symptoms, clinical context, and patient history). We assessed associations of RFS and mortality within 180 days (primary endpoint) and other secondary endpoints using multivariable regression analysis. Among 967 included patients, RFS was confirmed in 141 (14.6%) patients. Compared to patients with no evidence for RFS, patients with confirmed RFS had significantly increased 180-days mortality rates (42/141 (29.8%) vs 181/826 (21.9%), adjusted odds ratio (OR) 1.53 (95% CI 1.02 to 2.29), P < .05). Patients with RFS also had an increased risk for ICU admission (6/141 (4.3%) vs 13/826 (1.6%), adjusted OR 2.71 (95% CI 1.01 to 7.27), P < .05) and longer mean length of hospital stays (10.5 ± 6.9 vs 9.0 ± 6.6 days, adjusted difference 1.57 days (95% CI 0.38-2.75), P = .01). A relevant proportion of medical inpatients with malnutrition develop features of RFS upon hospital admission, which is associated with long-term mortality and other adverse clinical outcomes. Further studies are needed to develop preventive strategies for RFS in this patient population.
Sections du résumé
BACKGROUND
BACKGROUND
Whether the occurrence of refeeding syndrome (RFS), a metabolic condition characterized by electrolyte shifts after initiation of nutritional therapy, has a negative impact on clinical outcomes remains ill-defined. We prospectively investigated a subgroup of patients included in a multicentre, nutritional trial (EFFORT) for the occurrence of RFS.
METHODS
METHODS
In this secondary analysis of a randomized-controlled trial investigating the effects of nutritional support in malnourished medical inpatients, we prospectively screened patients for RFS and classified them as "RFS confirmed" and "RFS not confirmed" based on predefined criteria (i.e. electrolyte shifts, clinical symptoms, clinical context, and patient history). We assessed associations of RFS and mortality within 180 days (primary endpoint) and other secondary endpoints using multivariable regression analysis.
RESULTS
RESULTS
Among 967 included patients, RFS was confirmed in 141 (14.6%) patients. Compared to patients with no evidence for RFS, patients with confirmed RFS had significantly increased 180-days mortality rates (42/141 (29.8%) vs 181/826 (21.9%), adjusted odds ratio (OR) 1.53 (95% CI 1.02 to 2.29), P < .05). Patients with RFS also had an increased risk for ICU admission (6/141 (4.3%) vs 13/826 (1.6%), adjusted OR 2.71 (95% CI 1.01 to 7.27), P < .05) and longer mean length of hospital stays (10.5 ± 6.9 vs 9.0 ± 6.6 days, adjusted difference 1.57 days (95% CI 0.38-2.75), P = .01).
CONCLUSION
CONCLUSIONS
A relevant proportion of medical inpatients with malnutrition develop features of RFS upon hospital admission, which is associated with long-term mortality and other adverse clinical outcomes. Further studies are needed to develop preventive strategies for RFS in this patient population.
Identifiants
pubmed: 31895785
doi: 10.1097/MD.0000000000018506
pii: 00005792-202001030-00022
pmc: PMC6946353
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
e18506Références
Nutrition. 2018 Mar;47:13-20
pubmed: 29429529
JPEN J Parenter Enteral Nutr. 1990 Jan-Feb;14(1):90-7
pubmed: 2109122
Rev Gastroenterol Mex. 1997 Oct-Dec;62(4):260-5
pubmed: 9580233
Nutrition. 2010 Feb;26(2):156-67
pubmed: 20122539
Clin Nutr. 2018 Feb;37(1):336-353
pubmed: 28802519
Clin Exp Gastroenterol. 2018 Jul 10;11:255-264
pubmed: 30022846
Pharmacotherapy. 1995 Nov-Dec;15(6):713-26
pubmed: 8602378
Crit Care. 2015 Jan 29;19:35
pubmed: 25886997
Clin Nutr. 2003 Jun;22(3):321-36
pubmed: 12765673
BMJ Open. 2013 Jan 11;3(1):
pubmed: 23315514
BMJ. 2008 Jun 28;336(7659):1495-8
pubmed: 18583681
Eur J Clin Nutr. 2018 Feb;72(2):307-308
pubmed: 29235556
Lancet. 2019 Jun 8;393(10188):2312-2321
pubmed: 31030981
J Nutr Metab. 2010;2010:
pubmed: 20798756
Nutrition. 2016 Jul-Aug;32(7-8):790-8
pubmed: 27160498
Eur J Clin Nutr. 2018 Jan;72(1):93-98
pubmed: 28812578
Stat Methods Med Res. 2001 Dec;10(6):375-92
pubmed: 11763548
J Clin Med. 2019 Jul 20;8(7):
pubmed: 31330781
Nutr Hosp. 1996 Mar-Apr;11(2):98-101
pubmed: 8695716
Nutrition. 2017 Mar;35:151-160
pubmed: 28087222
Swiss Med Wkly. 2019 Aug 11;149:w20112
pubmed: 31401806
Nutrition. 2001 Jul-Aug;17(7-8):632-7
pubmed: 11448586